Medical Application: Sepsis, a leading cause of death in hospitals worldwide.
Neonatal Sepsis is a life-threatening medical emergency where immediate antibiotic treatment is key to patient survival. Yet, it’s extremely challenging to diagnose at an early stage as newborns present nonspecific clinical signs and gold-standard diagnostic tests are slow, inaccurate, and expensive. This results in overdiagnosis and prolonged unnecessary antibiotic treatment for approximately 12% of all newborns. Those unnecessary treatments lead to serious adverse effects for the newborns, add substantial financial burdens to Neonatal intensive care units (NICUs), and amplifies the alarming increase of antibiotic resistance — Global Health Threat by the WHO.
NEOSENS revolutionizes Neonatal Sepsis diagnosis by…
Developing an AI-based point-of-care diagnostic assistant to provide an accurate sepsis score from a drop of blood.
Our Solution is…
Fast
Results in 30min (vs a week)
Accurate
Avoid ~2/3 of unnecessary treatments
Cost-effective
38% cost reduction per tested newborn
Our Supporters
Our Awards
The Founding Team
“Driven by innovation and empathy, the NEOSENS founding team is dedicated to revolutionizing neonatal sepsis diagnosis, bridging the healthcare gap for newborns worldwide. United in their mission, these innovators are transforming the future of neonatal care, ensuring every newborns, regardless of geography, receives the best start in life.”
